Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Utkarsh Doshi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Metabolism Letters|July 5, 2011
Higher throughput human hepatocyte assays for the evaluation of time-dependent inhibition of CYP3A4Albert P Li, Utkarsh Doshi
Journal of Biomolecular Screening|August 12, 2011
Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and inductionUtkarsh Doshi, Albert P Li
Current Drug Metabolism|April 6, 2012
Effects of culture duration on gene expression of P450 isoforms, uptake and efflux transporters in primary hepatocytes cultured in the absence and presence of interleukin-6: implications for experimental design for the evaluation of downregulatory effects of biotherapeuticsQian Yang, Utkarsh Doshi, Nicole Li, et al.
Drug Metabolism Letters|August 19, 2015
A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized CompoundsChi-Chi Peng, Utkarsh Doshi, Chandra Prakash, et al.
Journal of Applied Toxicology : JAT|June 4, 2020
In vitro evaluation of the metabolic stability of nine fragrance chemicals in trout and human hepatocytesJohn Weeks, Albert P Li, Utkarsh Doshi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2017
Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four DonorsMing-Chih David Ho, Nicholas Ring, Kirsten Amaral, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 11, 2016
Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic CellsZhen Ren, Si Chen, Jie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and anticonvulsant activity of new N-1',N-3'-disubstituted-2'H,3H,5'H-spiro-(2-benzofuran-1,4'-imidazolidine)-2',3,5'-trionesHardik J Patel, Joe Sarra, Francesco Caruso, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2018
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK ModelingJialin Mao, Utkarsh Doshi, Matthew Wright, et al.
Drug Metabolism Letters|March 18, 2014
Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytesQing Zhu, Haiyan Xia, Cindy Q Xia, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Metabolism Letters|July 5, 2011
Higher throughput human hepatocyte assays for the evaluation of time-dependent inhibition of CYP3A4Albert P Li, Utkarsh Doshi
Journal of Biomolecular Screening|August 12, 2011
Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and inductionUtkarsh Doshi, Albert P Li
Current Drug Metabolism|April 6, 2012
Effects of culture duration on gene expression of P450 isoforms, uptake and efflux transporters in primary hepatocytes cultured in the absence and presence of interleukin-6: implications for experimental design for the evaluation of downregulatory effects of biotherapeuticsQian Yang, Utkarsh Doshi, Nicole Li, et al.
Drug Metabolism Letters|August 19, 2015
A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized CompoundsChi-Chi Peng, Utkarsh Doshi, Chandra Prakash, et al.
Journal of Applied Toxicology : JAT|June 4, 2020
In vitro evaluation of the metabolic stability of nine fragrance chemicals in trout and human hepatocytesJohn Weeks, Albert P Li, Utkarsh Doshi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2017
Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four DonorsMing-Chih David Ho, Nicholas Ring, Kirsten Amaral, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 11, 2016
Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic CellsZhen Ren, Si Chen, Jie Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2006
Synthesis and anticonvulsant activity of new N-1',N-3'-disubstituted-2'H,3H,5'H-spiro-(2-benzofuran-1,4'-imidazolidine)-2',3,5'-trionesHardik J Patel, Joe Sarra, Francesco Caruso, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2018
Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK ModelingJialin Mao, Utkarsh Doshi, Matthew Wright, et al.
Drug Metabolism Letters|March 18, 2014
Culture duration-, donor-, and medium-dependent changes in OATP1B3-mediated telmisartan uptake in human hepatocytesQing Zhu, Haiyan Xia, Cindy Q Xia, et al.
Pageof 2